2型糖尿病并发视网膜病变患者血清人类软骨糖蛋白39及其与尿白蛋白排泄率的关系_Chinese Journal of Ocular Fundus Diseases

Authors：

 贾安奎 , 仲华 , 王小方 , 汪磊 , 张国林 , 林志强

453100 新乡医学院第一附属医院检验科;

Corresponding author：

贾安奎, Email: xyyfydx@126.com

Keywords：

糖尿病视网膜病变/病因学; 白蛋白尿

DOI：

10.3760/cma.j.issn.1005-1015.2014.02.018

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 贾安奎, 仲华, 王小方, 汪磊, 张国林, 林志强. 2型糖尿病并发视网膜病变患者血清人类软骨糖蛋白39及其与尿白蛋白排泄率的关系. Chinese Journal of Ocular Fundus Diseases, 2014, 30(2): 194-196. doi: 10.3760/cma.j.issn.1005-1015.2014.02.018 Copy

1.	de Zeeuw D, Parving HH, Henning RH. Microalbuminuria as an early marker for cardiovascular disease[J]. J Am Soc Nephrol, 2006, 17:2100-2105.
2.	Thomas GN, Lin JW, Lam WW, et al. Albuminuria is a marker of increasing intracranial and extracranial vascular involvement in type 2 diabetic Chinese patients[J]. Diabetologia, 2004, 47:1528-1534.
3.	Chen HB, Zheng Z, Huang Y, et al. A microalbuminuria threshold to predict the risk for the development of diabetic retinopathy in type 2 diabetes mellitus patients[J/OL]. PLoS One, 2012, 7:E36718[2013-05-02]. http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0036718.
4.	Rathcke CN, Vestergaard H. YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis[J]. Inflamm Res, 2006, 55:221-227.
5.	Brix JM, H llerl F, Koppensteiner R, et al. YKL-40 in type 2 diabetic patients with different levels of albuminuria[J]. Eur J Clin Invest, 2011, 41:589-596.
6.	Røndbjerg AK, Omerovic E, Vestergaard H. YKL-40 levels are independently associated with albuminuria in type 2 diabetes[J/OL]. Cardiovasc Diabetol, 2011, 10:54[2013-04-08]. http://www.cardiab.com/content/10/1/54.
7.	Johansen JS, Jensen BV, Roslind A, et al. Serum YKL-40, a new prognostic biomarker in cancer patients?[J]. Cancer Epidemiol Biomarkers Prev, 2006, 15:194-202.
8.	Rathcke CN, Johansen JS, Vestergaard H. YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance[J]. Inflamm Res, 2006, 55:53-59.
9.	Rathcke CN, Vestergaard H. YKL-40--an emerging biomarker in cardiovascular disease and diabetes[J/OL]. Cardiovasc Diabetol, 2009, 8:61[2013-04-08]. http://www.cardiab.com/content/8/1/61.
10.	Nielsen AR, Erikstrup C, Johansen JS, et al. Plasma YKL-40:a BMI-independent marker of type 2 diabetes[J]. Diabetes, 2008, 57:3078-3082.
11.	Sakamoto F, Katakami N, Kaneto H, et al. Association of serum YKL-40 levels with urinary albumin excretion rate in young Japanese patients with type 1 diabetes mellitus[J]. Endocr J, 2013, 60:73-79.
12.	施彩虹, 朱鸿.尿白蛋白在糖尿病性视网膜病变患者不同时期的变化及应用价值分析[J].眼视光学杂志, 2008, 10:262-265.

1. de Zeeuw D, Parving HH, Henning RH. Microalbuminuria as an early marker for cardiovascular disease[J]. J Am Soc Nephrol, 2006, 17:2100-2105.
2. Thomas GN, Lin JW, Lam WW, et al. Albuminuria is a marker of increasing intracranial and extracranial vascular involvement in type 2 diabetic Chinese patients[J]. Diabetologia, 2004, 47:1528-1534.
3. Chen HB, Zheng Z, Huang Y, et al. A microalbuminuria threshold to predict the risk for the development of diabetic retinopathy in type 2 diabetes mellitus patients[J/OL]. PLoS One, 2012, 7:E36718[2013-05-02]. http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0036718.
4. Rathcke CN, Vestergaard H. YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis[J]. Inflamm Res, 2006, 55:221-227.
5. Brix JM, H llerl F, Koppensteiner R, et al. YKL-40 in type 2 diabetic patients with different levels of albuminuria[J]. Eur J Clin Invest, 2011, 41:589-596.
6. Røndbjerg AK, Omerovic E, Vestergaard H. YKL-40 levels are independently associated with albuminuria in type 2 diabetes[J/OL]. Cardiovasc Diabetol, 2011, 10:54[2013-04-08]. http://www.cardiab.com/content/10/1/54.
7. Johansen JS, Jensen BV, Roslind A, et al. Serum YKL-40, a new prognostic biomarker in cancer patients?[J]. Cancer Epidemiol Biomarkers Prev, 2006, 15:194-202.
8. Rathcke CN, Johansen JS, Vestergaard H. YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance[J]. Inflamm Res, 2006, 55:53-59.
9. Rathcke CN, Vestergaard H. YKL-40--an emerging biomarker in cardiovascular disease and diabetes[J/OL]. Cardiovasc Diabetol, 2009, 8:61[2013-04-08]. http://www.cardiab.com/content/8/1/61.
10. Nielsen AR, Erikstrup C, Johansen JS, et al. Plasma YKL-40:a BMI-independent marker of type 2 diabetes[J]. Diabetes, 2008, 57:3078-3082.
11. Sakamoto F, Katakami N, Kaneto H, et al. Association of serum YKL-40 levels with urinary albumin excretion rate in young Japanese patients with type 1 diabetes mellitus[J]. Endocr J, 2013, 60:73-79.
12. 施彩虹, 朱鸿.尿白蛋白在糖尿病性视网膜病变患者不同时期的变化及应用价值分析[J].眼视光学杂志, 2008, 10:262-265.

Chinese Journal of Ocular Fundus Diseases

2型糖尿病并发视网膜病变患者血清人类软骨糖蛋白39及其与尿白蛋白排泄率的关系

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content